The author describes various manufacturing processes and evaluates whether the guidance can be applied to each of them.
May 1, 2009
By:James P. Agalloco
The author describes various manufacturing processes and evaluates whether the guidance can be applied to each of them.
 |
Patient safety must be the primary concern of any validation effort. The author explains how a risk-based approach to validation and compliance follows naturally from this premise.
Jul 2, 2008
By:James P. Agalloco
Patient safety must be the primary concern of any validation effort. The author explains how a risk-based approach to validation and compliance follows naturally from this premise.
|
Feb 20, 2008
By:James P. Agalloco
Preparing sterile products requires manufacturers to control microbial quality. Sterility and endotoxin content are critical because failure to properly manage them can seriously harm, or even kill, patients.
|
The authors examine advances in the design and the application of biological indicator evaluator resistometer vessels used to measure the resistance of bacterial spores in monitoring sterilization processes.
Aug 2, 2007
By:Kurt McCauley, John R. Gillis, James P. Agalloco
The authors examine advances in the design and the application of biological indicator evaluator resistometer vessels used to measure the resistance of bacterial spores in monitoring sterilization processes.
|
Aseptic processing has advanced over the past several decades, yet the pharmaceutical industry is still accepting of its limitations, particularly as it relates to human intervention as a source of contamination. The authors explain the importance of further diminishing the role of operators in aseptic processing and the approaches and technologies needed to achieve that goal.
May 1, 2007
By:James E. Akers, James P. Agalloco
Aseptic processing has advanced over the past several decades, yet the pharmaceutical industry is still accepting of its limitations, particularly as it relates to human intervention as a source of contamination. The authors explain the importance of further diminishing the role of operators in aseptic processing and the approaches and technologies needed to achieve that goal.
|
The author clarifies the definition and objectives of overkill sterilization for steam sterilization cycles. Current sterilization practices are reviewed and the validation difficulties associated with the various definitions of overkill sterilization are explored.
May 1, 2007
By:James P. Agalloco
The author clarifies the definition and objectives of overkill sterilization for steam sterilization cycles. Current sterilization practices are reviewed and the validation difficulties associated with the various definitions of overkill sterilization are explored.
|
This article summarizes changes to the Akers–Agalloco aseptic processing risk analysis model (first presented in Pharmaceutical Technology's November 2005 issue) as well as some of the underlying thinking behind the revision. The simplified model makes the method easier to use because of its greater flexibility of environmental control practice. It maintains the emphasis on human activity as the primary consideration in risk management for aseptic processing.
Jul 2, 2006
By:James E. Akers, James P. Agalloco
This article summarizes changes to the Akers–Agalloco aseptic processing risk analysis model (first presented in Pharmaceutical Technology's November 2005 issue) as well as some of the underlying thinking behind the revision. The simplified model makes the method easier to use because of its greater flexibility of environmental control practice. It maintains the emphasis on human activity as the primary consideration in risk management for aseptic processing.
|
May 1, 2006
By:James P. Agalloco
There are few, if any, valid reasons not to install an isolator in a new aseptic processing facility.
|
May 1, 2006
By:James P. Agalloco, James E. Akers
Any aseptic processing technology that allows intervention by
gowned personnel during operation cannot be considered an advanced
technology. Although a standardized definition of restricted access
barrier systems has been developed, these systems fall well short
of being classfied as advanced technologies.
|
| 
Speed, Resolution, Reproducibility, Flexibility, Durability: Unmatched in sample throughput & data precision, Shimadzu's Prominence Ultrafast LC (UFLC) delivers data without compromise. Learn more.
Processing & Packaging Online Auction - November 24th, 2009 - 9-4 ET
DJS Enterprises - Since 1991 buying and selling high quality, reasonably priced New, Used and Reconditioned Process and Packaging Equipment for the Pharmaceutical, Vitamin, Food and Confectionery Industries.
Buy new and used pharmaceutical equipment, used process equipment and laboratory equipment at LabX. Auctions, classifieds, and post FREE wanted ads to locate equipment.
Swagelok® DR series valve design saves space, minimizes entrapment, extends diaphragm life. See how.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
Million Dollar Biotech & Pharmaceutical Equipment Online Auctions